You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Dow
McKinsey
Mallinckrodt
Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NALTREXONE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for naltrexone

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000195 Neurobiology of Opioid Dependence: 4 - 4 Withdrawn Yale University Phase 2 1993-01-01 The purpose of this study is to determine the effect of chronic naltrexone pre-treatment on the response to yohimbine in healthy volunteers.
NCT00000196 Neurobiology of Opioid Dependence: 5 - 5 Withdrawn National Institute on Drug Abuse (NIDA) Phase 2 1993-01-01 The purpose of this study is to determine the effect of acute naltrexone pretreatment on the response to yohimbine in healthy volunteers.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for naltrexone

Condition Name

Condition Name for naltrexone
Intervention Trials
Alcoholism 53
Alcohol Dependence 48
Obesity 22
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for naltrexone
Intervention Trials
Alcoholism 104
Opioid-Related Disorders 48
Disease 39
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for naltrexone

Trials by Country

Trials by Country for naltrexone
Location Trials
United States 685
Germany 13
China 12
Canada 12
Russian Federation 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for naltrexone
Location Trials
New York 60
Connecticut 51
Pennsylvania 44
California 44
Texas 35
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for naltrexone

Clinical Trial Phase

Clinical Trial Phase for naltrexone
Clinical Trial Phase Trials
Phase 4 84
Phase 3 60
Phase 2/Phase 3 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for naltrexone
Clinical Trial Phase Trials
Completed 230
Recruiting 61
Not yet recruiting 44
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for naltrexone

Sponsor Name

Sponsor Name for naltrexone
Sponsor Trials
National Institute on Drug Abuse (NIDA) 82
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 56
Yale University 34
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for naltrexone
Sponsor Trials
Other 384
NIH 154
Industry 99
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.